The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hemoglobinopathy Testing Services Market Research Report 2025
Synopsis
Hemoglobinopathy includes a range of disorders, which occur due to altered structure of hemoglobin. Hemoglobin is present in the red blood cells that transports oxygen from the lung to the body.
The global Hemoglobinopathy Testing Services market was valued at US$ 825 million in 2023 and is anticipated to reach US$ 1558.4 million by 2030, witnessing a CAGR of 9.4% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hemoglobinopathy Testing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoglobinopathy Testing Services.
Report Scope
The Hemoglobinopathy Testing Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemoglobinopathy Testing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemoglobinopathy Testing Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
AstraZeneca
Bluebird Bio
Bristol-Myers Squibb
Emmaus Medical
Acceleron Pharma
HemaQuest Pharmaceuticals
Eli Lilly and Company
Celgene Corporation
Segment by Type
Hydroxyurea
Glutamine
Zynteglo
Luspatercept
Others
Segment by Application
Sickle Cell Diseases
Thalassemia
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemoglobinopathy Testing Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Hemoglobinopathy includes a range of disorders, which occur due to altered structure of hemoglobin. Hemoglobin is present in the red blood cells that transports oxygen from the lung to the body.
The global Hemoglobinopathy Testing Services market was valued at US$ 825 million in 2023 and is anticipated to reach US$ 1558.4 million by 2030, witnessing a CAGR of 9.4% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hemoglobinopathy Testing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoglobinopathy Testing Services.
Report Scope
The Hemoglobinopathy Testing Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemoglobinopathy Testing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemoglobinopathy Testing Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
AstraZeneca
Bluebird Bio
Bristol-Myers Squibb
Emmaus Medical
Acceleron Pharma
HemaQuest Pharmaceuticals
Eli Lilly and Company
Celgene Corporation
Segment by Type
Hydroxyurea
Glutamine
Zynteglo
Luspatercept
Others
Segment by Application
Sickle Cell Diseases
Thalassemia
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemoglobinopathy Testing Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemoglobinopathy Testing Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hydroxyurea
1.2.3 Glutamine
1.2.4 Zynteglo
1.2.5 Luspatercept
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hemoglobinopathy Testing Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Sickle Cell Diseases
1.3.3 Thalassemia
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemoglobinopathy Testing Services Market Perspective (2019-2030)
2.2 Hemoglobinopathy Testing Services Growth Trends by Region
2.2.1 Global Hemoglobinopathy Testing Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hemoglobinopathy Testing Services Historic Market Size by Region (2019-2024)
2.2.3 Hemoglobinopathy Testing Services Forecasted Market Size by Region (2025-2030)
2.3 Hemoglobinopathy Testing Services Market Dynamics
2.3.1 Hemoglobinopathy Testing Services Industry Trends
2.3.2 Hemoglobinopathy Testing Services Market Drivers
2.3.3 Hemoglobinopathy Testing Services Market Challenges
2.3.4 Hemoglobinopathy Testing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemoglobinopathy Testing Services Players by Revenue
3.1.1 Global Top Hemoglobinopathy Testing Services Players by Revenue (2019-2024)
3.1.2 Global Hemoglobinopathy Testing Services Revenue Market Share by Players (2019-2024)
3.2 Global Hemoglobinopathy Testing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hemoglobinopathy Testing Services Revenue
3.4 Global Hemoglobinopathy Testing Services Market Concentration Ratio
3.4.1 Global Hemoglobinopathy Testing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemoglobinopathy Testing Services Revenue in 2023
3.5 Hemoglobinopathy Testing Services Key Players Head office and Area Served
3.6 Key Players Hemoglobinopathy Testing Services Product Solution and Service
3.7 Date of Enter into Hemoglobinopathy Testing Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemoglobinopathy Testing Services Breakdown Data by Type
4.1 Global Hemoglobinopathy Testing Services Historic Market Size by Type (2019-2024)
4.2 Global Hemoglobinopathy Testing Services Forecasted Market Size by Type (2025-2030)
5 Hemoglobinopathy Testing Services Breakdown Data by Application
5.1 Global Hemoglobinopathy Testing Services Historic Market Size by Application (2019-2024)
5.2 Global Hemoglobinopathy Testing Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hemoglobinopathy Testing Services Market Size (2019-2030)
6.2 North America Hemoglobinopathy Testing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hemoglobinopathy Testing Services Market Size by Country (2019-2024)
6.4 North America Hemoglobinopathy Testing Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hemoglobinopathy Testing Services Market Size (2019-2030)
7.2 Europe Hemoglobinopathy Testing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hemoglobinopathy Testing Services Market Size by Country (2019-2024)
7.4 Europe Hemoglobinopathy Testing Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hemoglobinopathy Testing Services Market Size (2019-2030)
8.2 Asia-Pacific Hemoglobinopathy Testing Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hemoglobinopathy Testing Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Hemoglobinopathy Testing Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hemoglobinopathy Testing Services Market Size (2019-2030)
9.2 Latin America Hemoglobinopathy Testing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hemoglobinopathy Testing Services Market Size by Country (2019-2024)
9.4 Latin America Hemoglobinopathy Testing Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemoglobinopathy Testing Services Market Size (2019-2030)
10.2 Middle East & Africa Hemoglobinopathy Testing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hemoglobinopathy Testing Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Hemoglobinopathy Testing Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Hemoglobinopathy Testing Services Introduction
11.1.4 Novartis Revenue in Hemoglobinopathy Testing Services Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Hemoglobinopathy Testing Services Introduction
11.2.4 AstraZeneca Revenue in Hemoglobinopathy Testing Services Business (2019-2024)
11.2.5 AstraZeneca Recent Development
11.3 Bluebird Bio
11.3.1 Bluebird Bio Company Detail
11.3.2 Bluebird Bio Business Overview
11.3.3 Bluebird Bio Hemoglobinopathy Testing Services Introduction
11.3.4 Bluebird Bio Revenue in Hemoglobinopathy Testing Services Business (2019-2024)
11.3.5 Bluebird Bio Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Hemoglobinopathy Testing Services Introduction
11.4.4 Bristol-Myers Squibb Revenue in Hemoglobinopathy Testing Services Business (2019-2024)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Emmaus Medical
11.5.1 Emmaus Medical Company Detail
11.5.2 Emmaus Medical Business Overview
11.5.3 Emmaus Medical Hemoglobinopathy Testing Services Introduction
11.5.4 Emmaus Medical Revenue in Hemoglobinopathy Testing Services Business (2019-2024)
11.5.5 Emmaus Medical Recent Development
11.6 Acceleron Pharma
11.6.1 Acceleron Pharma Company Detail
11.6.2 Acceleron Pharma Business Overview
11.6.3 Acceleron Pharma Hemoglobinopathy Testing Services Introduction
11.6.4 Acceleron Pharma Revenue in Hemoglobinopathy Testing Services Business (2019-2024)
11.6.5 Acceleron Pharma Recent Development
11.7 HemaQuest Pharmaceuticals
11.7.1 HemaQuest Pharmaceuticals Company Detail
11.7.2 HemaQuest Pharmaceuticals Business Overview
11.7.3 HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Introduction
11.7.4 HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Testing Services Business (2019-2024)
11.7.5 HemaQuest Pharmaceuticals Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Detail
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Hemoglobinopathy Testing Services Introduction
11.8.4 Eli Lilly and Company Revenue in Hemoglobinopathy Testing Services Business (2019-2024)
11.8.5 Eli Lilly and Company Recent Development
11.9 Celgene Corporation
11.9.1 Celgene Corporation Company Detail
11.9.2 Celgene Corporation Business Overview
11.9.3 Celgene Corporation Hemoglobinopathy Testing Services Introduction
11.9.4 Celgene Corporation Revenue in Hemoglobinopathy Testing Services Business (2019-2024)
11.9.5 Celgene Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Hemoglobinopathy Testing Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hydroxyurea
Table 3. Key Players of Glutamine
Table 4. Key Players of Zynteglo
Table 5. Key Players of Luspatercept
Table 6. Key Players of Others
Table 7. Global Hemoglobinopathy Testing Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Hemoglobinopathy Testing Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Hemoglobinopathy Testing Services Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Hemoglobinopathy Testing Services Market Share by Region (2019-2024)
Table 11. Global Hemoglobinopathy Testing Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Hemoglobinopathy Testing Services Market Share by Region (2025-2030)
Table 13. Hemoglobinopathy Testing Services Market Trends
Table 14. Hemoglobinopathy Testing Services Market Drivers
Table 15. Hemoglobinopathy Testing Services Market Challenges
Table 16. Hemoglobinopathy Testing Services Market Restraints
Table 17. Global Hemoglobinopathy Testing Services Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Hemoglobinopathy Testing Services Market Share by Players (2019-2024)
Table 19. Global Top Hemoglobinopathy Testing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathy Testing Services as of 2023)
Table 20. Ranking of Global Top Hemoglobinopathy Testing Services Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Hemoglobinopathy Testing Services Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hemoglobinopathy Testing Services Product Solution and Service
Table 24. Date of Enter into Hemoglobinopathy Testing Services Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hemoglobinopathy Testing Services Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Hemoglobinopathy Testing Services Revenue Market Share by Type (2019-2024)
Table 28. Global Hemoglobinopathy Testing Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Hemoglobinopathy Testing Services Revenue Market Share by Type (2025-2030)
Table 30. Global Hemoglobinopathy Testing Services Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Hemoglobinopathy Testing Services Revenue Market Share by Application (2019-2024)
Table 32. Global Hemoglobinopathy Testing Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Hemoglobinopathy Testing Services Revenue Market Share by Application (2025-2030)
Table 34. North America Hemoglobinopathy Testing Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Hemoglobinopathy Testing Services Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Hemoglobinopathy Testing Services Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Hemoglobinopathy Testing Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Hemoglobinopathy Testing Services Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Hemoglobinopathy Testing Services Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Hemoglobinopathy Testing Services Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Hemoglobinopathy Testing Services Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Hemoglobinopathy Testing Services Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Hemoglobinopathy Testing Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Hemoglobinopathy Testing Services Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Hemoglobinopathy Testing Services Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Hemoglobinopathy Testing Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Hemoglobinopathy Testing Services Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Hemoglobinopathy Testing Services Market Size by Country (2025-2030) & (US$ Million)
Table 49. Novartis Company Detail
Table 50. Novartis Business Overview
Table 51. Novartis Hemoglobinopathy Testing Services Product
Table 52. Novartis Revenue in Hemoglobinopathy Testing Services Business (2019-2024) & (US$ Million)
Table 53. Novartis Recent Development
Table 54. AstraZeneca Company Detail
Table 55. AstraZeneca Business Overview
Table 56. AstraZeneca Hemoglobinopathy Testing Services Product
Table 57. AstraZeneca Revenue in Hemoglobinopathy Testing Services Business (2019-2024) & (US$ Million)
Table 58. AstraZeneca Recent Development
Table 59. Bluebird Bio Company Detail
Table 60. Bluebird Bio Business Overview
Table 61. Bluebird Bio Hemoglobinopathy Testing Services Product
Table 62. Bluebird Bio Revenue in Hemoglobinopathy Testing Services Business (2019-2024) & (US$ Million)
Table 63. Bluebird Bio Recent Development
Table 64. Bristol-Myers Squibb Company Detail
Table 65. Bristol-Myers Squibb Business Overview
Table 66. Bristol-Myers Squibb Hemoglobinopathy Testing Services Product
Table 67. Bristol-Myers Squibb Revenue in Hemoglobinopathy Testing Services Business (2019-2024) & (US$ Million)
Table 68. Bristol-Myers Squibb Recent Development
Table 69. Emmaus Medical Company Detail
Table 70. Emmaus Medical Business Overview
Table 71. Emmaus Medical Hemoglobinopathy Testing Services Product
Table 72. Emmaus Medical Revenue in Hemoglobinopathy Testing Services Business (2019-2024) & (US$ Million)
Table 73. Emmaus Medical Recent Development
Table 74. Acceleron Pharma Company Detail
Table 75. Acceleron Pharma Business Overview
Table 76. Acceleron Pharma Hemoglobinopathy Testing Services Product
Table 77. Acceleron Pharma Revenue in Hemoglobinopathy Testing Services Business (2019-2024) & (US$ Million)
Table 78. Acceleron Pharma Recent Development
Table 79. HemaQuest Pharmaceuticals Company Detail
Table 80. HemaQuest Pharmaceuticals Business Overview
Table 81. HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Product
Table 82. HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Testing Services Business (2019-2024) & (US$ Million)
Table 83. HemaQuest Pharmaceuticals Recent Development
Table 84. Eli Lilly and Company Company Detail
Table 85. Eli Lilly and Company Business Overview
Table 86. Eli Lilly and Company Hemoglobinopathy Testing Services Product
Table 87. Eli Lilly and Company Revenue in Hemoglobinopathy Testing Services Business (2019-2024) & (US$ Million)
Table 88. Eli Lilly and Company Recent Development
Table 89. Celgene Corporation Company Detail
Table 90. Celgene Corporation Business Overview
Table 91. Celgene Corporation Hemoglobinopathy Testing Services Product
Table 92. Celgene Corporation Revenue in Hemoglobinopathy Testing Services Business (2019-2024) & (US$ Million)
Table 93. Celgene Corporation Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemoglobinopathy Testing Services Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hemoglobinopathy Testing Services Market Share by Type: 2023 VS 2030
Figure 3. Hydroxyurea Features
Figure 4. Glutamine Features
Figure 5. Zynteglo Features
Figure 6. Luspatercept Features
Figure 7. Others Features
Figure 8. Global Hemoglobinopathy Testing Services Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Hemoglobinopathy Testing Services Market Share by Application: 2023 VS 2030
Figure 10. Sickle Cell Diseases Case Studies
Figure 11. Thalassemia Case Studies
Figure 12. Other Case Studies
Figure 13. Hemoglobinopathy Testing Services Report Years Considered
Figure 14. Global Hemoglobinopathy Testing Services Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Hemoglobinopathy Testing Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Hemoglobinopathy Testing Services Market Share by Region: 2023 VS 2030
Figure 17. Global Hemoglobinopathy Testing Services Market Share by Players in 2023
Figure 18. Global Top Hemoglobinopathy Testing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathy Testing Services as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Hemoglobinopathy Testing Services Revenue in 2023
Figure 20. North America Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Hemoglobinopathy Testing Services Market Share by Country (2019-2030)
Figure 22. United States Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Hemoglobinopathy Testing Services Market Share by Country (2019-2030)
Figure 26. Germany Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Hemoglobinopathy Testing Services Market Share by Region (2019-2030)
Figure 34. China Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Hemoglobinopathy Testing Services Market Share by Country (2019-2030)
Figure 42. Mexico Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Hemoglobinopathy Testing Services Market Share by Country (2019-2030)
Figure 46. Turkey Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Hemoglobinopathy Testing Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Novartis Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2019-2024)
Figure 49. AstraZeneca Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2019-2024)
Figure 50. Bluebird Bio Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2019-2024)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2019-2024)
Figure 52. Emmaus Medical Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2019-2024)
Figure 53. Acceleron Pharma Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2019-2024)
Figure 54. HemaQuest Pharmaceuticals Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2019-2024)
Figure 55. Eli Lilly and Company Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2019-2024)
Figure 56. Celgene Corporation Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
